Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-centered prioritization of bladder cancer research.
Smith AB, Chisolm S, Deal A, Spangler A, Quale DZ, Bangs R, Jones JM, Gore JL. Smith AB, et al. Among authors: chisolm s. Cancer. 2018 Aug 1;124(15):3136-3144. doi: 10.1002/cncr.31530. Epub 2018 May 4. Cancer. 2018. PMID: 29727033 Free article.
Patient empowerment through engagement in bladder cancer research.
Hamad J, Gore J, Chisolm S, Powell M, Lavallee DC, Lipman R, Lindsey N, Smith A. Hamad J, et al. Among authors: chisolm s. Urol Oncol. 2021 Mar;39(3):193.e13-193.e19. doi: 10.1016/j.urolonc.2020.07.015. Epub 2020 Aug 28. Urol Oncol. 2021. PMID: 32863122
Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high-risk non-muscle-invasive bladder cancer.
Smith AB, Lee JR, Lawrence SO, Ho O, Lavallee DC, Chisolm S, MacLean DB, Louwers RK, Wolff EM, Kessler LG, Follmer KM, Gore JL. Smith AB, et al. Among authors: chisolm s. Cancer. 2022 Jan 1;128(1):103-111. doi: 10.1002/cncr.33897. Epub 2021 Sep 8. Cancer. 2022. PMID: 34495550 Free article.
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop.
Chang E, Apolo AB, Bangs R, Chisolm S, Duddalwar V, Efstathiou JA, Goldberg KB, Hansel DE, Kamat AM, Kluetz PG, Lerner SP, Plimack E, Prowell T, Singh H, Suzman D, Yu EY, Zhang H, Beaver JA, Pazdur R, Weinstock C, Galsky MD. Chang E, et al. Among authors: chisolm s. Nat Rev Urol. 2022 Jan;19(1):37-46. doi: 10.1038/s41585-021-00505-w. Epub 2021 Sep 10. Nat Rev Urol. 2022. PMID: 34508246 Review.
Urologic oncology patient perspectives during COVID-19 treatment delays.
Faris A, Herrel L, Montie JE, Chisolm S, Duby A, Wittmann D. Faris A, et al. Among authors: chisolm s. Support Care Cancer. 2022 Aug;30(8):7015-7020. doi: 10.1007/s00520-022-07028-z. Epub 2022 May 18. Support Care Cancer. 2022. PMID: 35583826 Free PMC article.
The effect of treatment on work productivity in patients with bladder cancer.
Ahlschlager L, McCabe S, Deal AM, Guo A, Gessner KH, Lipman R, Chisolm S, Gore JL, Smith AB. Ahlschlager L, et al. Among authors: chisolm s. Urol Oncol. 2023 Jun;41(6):293.e15-293.e21. doi: 10.1016/j.urolonc.2023.01.020. Epub 2023 Mar 27. Urol Oncol. 2023. PMID: 36990941 Free PMC article.
Bladder cancer patient and provider perspectives on smoking cessation.
Mossanen M, Smith AB, Onochie N, Matulewicz R, Bjurlin MA, Kibel AS, Abbas M, Shore N, Chisolm S, Bangs R, Cooper Z, Gore JL. Mossanen M, et al. Among authors: chisolm s. Urol Oncol. 2023 Nov;41(11):457.e9-457.e16. doi: 10.1016/j.urolonc.2023.08.017. Epub 2023 Oct 5. Urol Oncol. 2023. PMID: 37805339
46 results